|
Volumn 784, Issue 1, 2003, Pages 91-100
|
Development and validation of a bioanalytical method for the determination of the cholecystokinin type-1 (CCK1) receptor antagonist dexloxiglumide in human plasma
|
Author keywords
Cholecystokinin type 1; Dexloxiglumide; Receptor antagonist
|
Indexed keywords
CENTRIFUGATION;
EVAPORATION;
LIQUID CHROMATOGRAPHY;
ORGANIC SOLVENTS;
ULTRAVIOLET DETECTORS;
SUPERNATANTS;
BIOTECHNOLOGY;
CHOLECYSTOKININ;
CHOLECYSTOKININ RECEPTOR;
CHOLECYSTOKININ RECEPTOR BLOCKING AGENT;
DEXLOXIGLUMIDE;
LORGLUMIDE;
ORGANIC SOLVENT;
ACCURACY;
ACIDITY;
ANALYTIC METHOD;
ARTICLE;
BLOOD ANALYSIS;
CENTRIFUGATION;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
DRUG DETERMINATION;
DRUG METABOLISM;
DRUG STORAGE;
EVAPORATION;
HUMAN;
LIGHT ABSORPTION;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
REVERSED PHASE LIQUID CHROMATOGRAPHY;
SUPERNATANT;
VALIDATION PROCESS;
CALIBRATION;
HUMANS;
PENTANOIC ACIDS;
RECEPTORS, CHOLECYSTOKININ;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
|
EID: 0037464611
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/S1570-0232(02)00760-2 Document Type: Article |
Times cited : (3)
|
References (7)
|